Compositions and methods for ameliorating the clinical signs of an avian
pneumovirus (APV) infection in a bird are disclosed. The compositions include immunologically
effective amounts of an avirulent APV isolated from Canada geese. Methods for preparing
avirulent Canada goose APV compositions and vaccines are also described.